Although human data (61) revealed that fibrates improve diabetic nephropathy such as albuminuria, data from rodent studies demonstrate more effectiveness than those of clinical studies, suggesting that rodents are more sensitive to PPARα signaling. Here, PPARA is linked to diabetic kidney disease.